Loading...
Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors
A limiting factor for the use of adeno-associated viruses (AAVs) as vectors in gene therapy is the broad tropism of AAV serotypes, i.e., the parallel infection of several cell types. Nanobodies are single immunoglobulin variable domains from heavy chain antibodies that naturally occur in camelids. T...
Na minha lista:
| Udgivet i: | Mol Ther Methods Clin Dev |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Gene & Cell Therapy
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6819893/ https://ncbi.nlm.nih.gov/pubmed/31687421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2019.09.003 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|